A Frozen Embryo Transfer, or FET, is a process used in in-vitro fertilization (IVF) where a previously frozen embryo is thawed and transferred into the uterus. This approach allows individuals and couples to delay embryo implantation until the optimal time, both physically and emotionally. Embryos used in FET are typically created during a prior IVF cycle and then cryopreserved (frozen) at the blastocyst stage.
FET has become a popular option for many intended parents and gestational surrogates for several reasons:
The surrogate’s body ovulates naturally, and the embryo transfer is timed accordingly. This approach avoids hormone medications but requires close monitoring.
Involves estrogen and progesterone to prepare the endometrial lining and precisely control timing. Most U.S. clinics prefer this method for surrogates due to predictability and improved scheduling.
FET success depends on several factors, including:
Across U.S. clinics, FET success rates typically range from 40% to 65% per transfer. Surrogates often have even higher odds. See CDC ART stats and U.S. Health & Human Services for support and legal resources.
Frozen embryo transfer is a cornerstone of modern assisted reproduction, offering hope, flexibility, and science-backed success. For intended parents working with a surrogate, understanding every stage of FET — from hormones to hospital bags — is empowering and practical.
Surrogacy is an act of profound generosity and collaboration. Whether you’re the intended parent or the gestational carrier, know this: each careful step — including FET — brings you closer to a miracle in the making.